<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Rotenone inhibits Mitochondrial complex I — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Rotenone</strong>
  <span class="pred">&mdash;inhibits&rarr;</span>
  <strong>Mitochondrial complex I</strong>
</div>
<div class="entity-id">CHEBI:28201 &nbsp;&middot;&nbsp; UNKNOWN:Mitochondrial complex I</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 128.07<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.00 (Physical, 1 paper)<br>Score from 21 citations: <strong>128.07</strong><br><span style="color:#888">18&times; supports (+120.06) &middot; 1&times; contradicts (+8.00) &middot; 2&times; applies (+0.01)</span></div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1007/s11306-017-1213-z">10.1007/s11306-017-1213-z</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS401">MTBLS401</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 21 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>18</span><span class="cite-subtotal">&middot; +120.06</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">11-variable panel (MRI + proteins + metabolites) — distinguishes → Secondary Progressive Multiple Sclerosis vs Relapsing-Remitting Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/56eb1abeb169597e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">galectin-9 — distinguishes → Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/1450095c7b4c42c0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">monocyte chemoattractant protein-1 (MCP-1) — distinguishes → Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/00d2a2d192c1b6c9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">transforming growth factor alpha (TGF-α) — distinguishes → Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/335006889d363346.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">tumor necrosis factor alpha (TNF-α) — distinguishes → Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/685bab8fba4fef9d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">soluble CD40L (sCD40L) — distinguishes → Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/24987065dcdbbaac.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">platelet-derived growth factor AA (PDGF-AA) — distinguishes → Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/2d09a89a7d904a63.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">20β-dihydrocortisol (20β-DHF) — distinguishes → Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/902399d92133c455.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">myelin basic protein (MBP) — is_biomarker_for → disability progression in Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/e84238faec099d7f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">macrophage-derived chemokine (MDC) — is_biomarker_for → disability progression in Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/c25843d41b24886a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">20β-dihydrocortisol (20β-DHF) — is_biomarker_for → disability progression in Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/65c2bcacb4f70273.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">5,6-dihydroxyprostaglandin F1a (5,6-DH-PGF1α) — is_biomarker_for → disability progression in Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/de3e38f5e9c7ed38.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Relative Standard Deviation (RSD) filtering — decreases → irreproducible features in QC samples</span><span class="cite-claim-weight">+0.01</span><a href="../claim/b1dd481dc562881f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">QC-based RSD filter (RSD ≤ 20%) — distinguishes → reproducible vs. irreproducible LC-MS features</span><span class="cite-claim-weight">+0.01</span><a href="../claim/b95bd1b070b42696.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">QC-based RSD filter (RSD ≤ 30%) — distinguishes → reproducible vs. irreproducible LC-MS features</span><span class="cite-claim-weight">+0.01</span><a href="../claim/debd21a714282a30.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Filtering pipeline (blank + RSD + missing value) — decreases → number of LC-MS features retained after filtering</span><span class="cite-claim-weight">+0.01</span><a href="../claim/ad8aa4344ec56873.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Missing value filter (&gt;50% samples) — decreases → sparse features in LC-MS metabolomics data</span><span class="cite-claim-weight">+0.01</span><a href="../claim/2d9fe085e6f3af1e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Systematic filtering approach — increases → data quality in untargeted LC-MS metabolomics</span><span class="cite-claim-weight">+0.01</span><a href="../claim/9057249ba13fd543.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:6px"></span><span>1</span><span class="cite-subtotal">&middot; +8.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">indolepyruvate — distinguishes → Secondary Progressive Multiple Sclerosis</span><span class="cite-claim-weight">+8.00</span><a href="../claim/d9f854e522d7e73e.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:11px"></span><span>2</span><span class="cite-subtotal">&middot; +0.01</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Blank filtering — decreases → false positive features in LC-MS metabolomics</span><span class="cite-claim-weight">+0.01</span><a href="../claim/627d8c69a56a49d7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Blank filter (fold-change ≥ 3 sample/blank) — distinguishes → authentic metabolite features vs. background contaminants</span><span class="cite-claim-weight">+0.01</span><a href="../claim/fe027963ab7c8232.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>00548769d0251769</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/CHEBI:28201">CHEBI:28201</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/UNKNOWN:Mitochondrial complex I">UNKNOWN:Mitochondrial complex I</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
